학술논문
Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial
Document Type
Article
Author
Source
In The Lancet Haematology May 2021 8(5):e344-e354
Subject
Language
ISSN
2352-3026